Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Other Operating Expenses (2020 - 2025)

Historic Other Operating Expenses for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to $60000.0.

  • Maravai Lifesciences Holdings' Other Operating Expenses fell 9996.11% to $60000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $284.0 million, marking a year-over-year increase of 858.77%. This contributed to the annual value of $315.0 million for FY2024, which is N/A changed from last year.
  • Per Maravai Lifesciences Holdings' latest filing, its Other Operating Expenses stood at $60000.0 for Q3 2025, which was down 9996.11% from $70.2 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Other Operating Expenses registered a high of $162.2 million during Q4 2024, and its lowest value of $60000.0 during Q3 2025.
  • Over the past 5 years, Maravai Lifesciences Holdings' median Other Operating Expenses value was $38.1 million (recorded in 2021), while the average stood at $50.6 million.
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Other Operating Expenses surged by 94726.05% in 2021, and later crashed by 9996.11% in 2025.
  • Over the past 5 years, Maravai Lifesciences Holdings' Other Operating Expenses (Quarter) stood at $11.2 million in 2021, then surged by 163.99% to $29.7 million in 2022, then increased by 6.93% to $31.8 million in 2023, then soared by 410.69% to $162.2 million in 2024, then tumbled by 99.96% to $60000.0 in 2025.
  • Its Other Operating Expenses stands at $60000.0 for Q3 2025, versus $70.2 million for Q2 2025 and $51.6 million for Q1 2025.